 | • レポートコード：QY2112C03869 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥686,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,029,000 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,372,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は静脈内抗体の世界市場の現状について調査・分析し、2027年までの市場を予測しました。静脈内抗体の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（IgG、IgA、IgM、IgE、IgD）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・静脈内抗体の世界市場概要 ・メーカー別の競争状況、市場シェア ・静脈内抗体の種類別市場規模：IgG、IgA、IgM、IgE、IgD ・静脈内抗体の用途別市場規模：病院、クリニック、その他 ・北米の静脈内抗体市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの静脈内抗体市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの静脈内抗体市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の静脈内抗体市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの静脈内抗体市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Baxter International、CSL Limited、Biotest AG、OMRIX Biopharmaceuticals、Octapharma AG、Grifols, S.A、Guizhou Taibang Biological Products、Shanghai RAAS Blood Products、Hualan Biological Engineering、Kedrion S.p.A.、Beijing Tiantan Biological Products、China Biologic Products ・静脈内抗体のバリューチェーン・販売チャネル分析 ・静脈内抗体の世界市場動向 |
Market Analysis and Insights: Global Intravenous Antibodies Market
The global Intravenous Antibodies market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
Global Intravenous Antibodies Scope and Segment
Intravenous Antibodies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
IgG
IgA
IgM
IgE
IgD
Segment by Application
Hospitals
Clinics
Others
By Company
Baxter International
CSL Limited
Biotest AG
OMRIX Biopharmaceuticals
Octapharma AG
Grifols, S.A
Guizhou Taibang Biological Products
Shanghai RAAS Blood Products
Hualan Biological Engineering
Kedrion S.p.A.
Beijing Tiantan Biological Products
China Biologic Products
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Intravenous Antibodies Product Introduction
1.2 Market by Type
1.2.1 Global Intravenous Antibodies Market Size Growth Rate by Type
1.2.2 IgG
1.2.3 IgA
1.2.4 IgM
1.2.5 IgE
1.2.6 IgD
1.3 Market by Application
1.3.1 Global Intravenous Antibodies Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intravenous Antibodies Sales Estimates and Forecasts 2016-2027
2.2 Global Intravenous Antibodies Revenue Estimates and Forecasts 2016-2027
2.3 Global Intravenous Antibodies Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Intravenous Antibodies Regions by Sales
2.4.1 Global Top Intravenous Antibodies Regions by Sales (2016-2021)
2.4.2 Global Top Intravenous Antibodies Regions by Sales (2022-2027)
2.5 Global Top Intravenous Antibodies Regions by Revenue
2.5.1 Global Top Intravenous Antibodies Regions by Revenue (2016-2021)
2.5.2 Global Top Intravenous Antibodies Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Intravenous Antibodies Sales by Manufacturers
3.1.1 Global Top Intravenous Antibodies Manufacturers by Sales (2016-2021)
3.1.2 Global Top Intravenous Antibodies Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Intravenous Antibodies Sales in 2020
3.2 Global Intravenous Antibodies Revenue by Manufacturers
3.2.1 Global Top Intravenous Antibodies Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Intravenous Antibodies Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Intravenous Antibodies Revenue in 2020
3.3 Global Intravenous Antibodies Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Intravenous Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Intravenous Antibodies Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intravenous Antibodies Sales by Type
4.1.1 Global Intravenous Antibodies Historical Sales by Type (2016-2021)
4.1.2 Global Intravenous Antibodies Forecasted Sales by Type (2022-2027)
4.1.3 Global Intravenous Antibodies Sales Market Share by Type (2016-2027)
4.2 Global Intravenous Antibodies Revenue by Type
4.2.1 Global Intravenous Antibodies Historical Revenue by Type (2016-2021)
4.2.2 Global Intravenous Antibodies Forecasted Revenue by Type (2022-2027)
4.2.3 Global Intravenous Antibodies Revenue Market Share by Type (2016-2027)
4.3 Global Intravenous Antibodies Price by Type
4.3.1 Global Intravenous Antibodies Price by Type (2016-2021)
4.3.2 Global Intravenous Antibodies Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Intravenous Antibodies Sales by Application
5.1.1 Global Intravenous Antibodies Historical Sales by Application (2016-2021)
5.1.2 Global Intravenous Antibodies Forecasted Sales by Application (2022-2027)
5.1.3 Global Intravenous Antibodies Sales Market Share by Application (2016-2027)
5.2 Global Intravenous Antibodies Revenue by Application
5.2.1 Global Intravenous Antibodies Historical Revenue by Application (2016-2021)
5.2.2 Global Intravenous Antibodies Forecasted Revenue by Application (2022-2027)
5.2.3 Global Intravenous Antibodies Revenue Market Share by Application (2016-2027)
5.3 Global Intravenous Antibodies Price by Application
5.3.1 Global Intravenous Antibodies Price by Application (2016-2021)
5.3.2 Global Intravenous Antibodies Price Forecast by Application (2022-2027)
6 North America
6.1 North America Intravenous Antibodies Market Size by Type
6.1.1 North America Intravenous Antibodies Sales by Type (2016-2027)
6.1.2 North America Intravenous Antibodies Revenue by Type (2016-2027)
6.2 North America Intravenous Antibodies Market Size by Application
6.2.1 North America Intravenous Antibodies Sales by Application (2016-2027)
6.2.2 North America Intravenous Antibodies Revenue by Application (2016-2027)
6.3 North America Intravenous Antibodies Market Size by Country
6.3.1 North America Intravenous Antibodies Sales by Country (2016-2027)
6.3.2 North America Intravenous Antibodies Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Intravenous Antibodies Market Size by Type
7.1.1 Europe Intravenous Antibodies Sales by Type (2016-2027)
7.1.2 Europe Intravenous Antibodies Revenue by Type (2016-2027)
7.2 Europe Intravenous Antibodies Market Size by Application
7.2.1 Europe Intravenous Antibodies Sales by Application (2016-2027)
7.2.2 Europe Intravenous Antibodies Revenue by Application (2016-2027)
7.3 Europe Intravenous Antibodies Market Size by Country
7.3.1 Europe Intravenous Antibodies Sales by Country (2016-2027)
7.3.2 Europe Intravenous Antibodies Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Intravenous Antibodies Market Size by Type
8.1.1 Asia Pacific Intravenous Antibodies Sales by Type (2016-2027)
8.1.2 Asia Pacific Intravenous Antibodies Revenue by Type (2016-2027)
8.2 Asia Pacific Intravenous Antibodies Market Size by Application
8.2.1 Asia Pacific Intravenous Antibodies Sales by Application (2016-2027)
8.2.2 Asia Pacific Intravenous Antibodies Revenue by Application (2016-2027)
8.3 Asia Pacific Intravenous Antibodies Market Size by Region
8.3.1 Asia Pacific Intravenous Antibodies Sales by Region (2016-2027)
8.3.2 Asia Pacific Intravenous Antibodies Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Intravenous Antibodies Market Size by Type
9.1.1 Latin America Intravenous Antibodies Sales by Type (2016-2027)
9.1.2 Latin America Intravenous Antibodies Revenue by Type (2016-2027)
9.2 Latin America Intravenous Antibodies Market Size by Application
9.2.1 Latin America Intravenous Antibodies Sales by Application (2016-2027)
9.2.2 Latin America Intravenous Antibodies Revenue by Application (2016-2027)
9.3 Latin America Intravenous Antibodies Market Size by Country
9.3.1 Latin America Intravenous Antibodies Sales by Country (2016-2027)
9.3.2 Latin America Intravenous Antibodies Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Intravenous Antibodies Market Size by Type
10.1.1 Middle East and Africa Intravenous Antibodies Sales by Type (2016-2027)
10.1.2 Middle East and Africa Intravenous Antibodies Revenue by Type (2016-2027)
10.2 Middle East and Africa Intravenous Antibodies Market Size by Application
10.2.1 Middle East and Africa Intravenous Antibodies Sales by Application (2016-2027)
10.2.2 Middle East and Africa Intravenous Antibodies Revenue by Application (2016-2027)
10.3 Middle East and Africa Intravenous Antibodies Market Size by Country
10.3.1 Middle East and Africa Intravenous Antibodies Sales by Country (2016-2027)
10.3.2 Middle East and Africa Intravenous Antibodies Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Baxter International
11.1.1 Baxter International Corporation Information
11.1.2 Baxter International Overview
11.1.3 Baxter International Intravenous Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Baxter International Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Baxter International Recent Developments
11.2 CSL Limited
11.2.1 CSL Limited Corporation Information
11.2.2 CSL Limited Overview
11.2.3 CSL Limited Intravenous Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 CSL Limited Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Limited Recent Developments
11.3 Biotest AG
11.3.1 Biotest AG Corporation Information
11.3.2 Biotest AG Overview
11.3.3 Biotest AG Intravenous Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Biotest AG Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biotest AG Recent Developments
11.4 OMRIX Biopharmaceuticals
11.4.1 OMRIX Biopharmaceuticals Corporation Information
11.4.2 OMRIX Biopharmaceuticals Overview
11.4.3 OMRIX Biopharmaceuticals Intravenous Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 OMRIX Biopharmaceuticals Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 OMRIX Biopharmaceuticals Recent Developments
11.5 Octapharma AG
11.5.1 Octapharma AG Corporation Information
11.5.2 Octapharma AG Overview
11.5.3 Octapharma AG Intravenous Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Octapharma AG Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Octapharma AG Recent Developments
11.6 Grifols, S.A
11.6.1 Grifols, S.A Corporation Information
11.6.2 Grifols, S.A Overview
11.6.3 Grifols, S.A Intravenous Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Grifols, S.A Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Grifols, S.A Recent Developments
11.7 Guizhou Taibang Biological Products
11.7.1 Guizhou Taibang Biological Products Corporation Information
11.7.2 Guizhou Taibang Biological Products Overview
11.7.3 Guizhou Taibang Biological Products Intravenous Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Guizhou Taibang Biological Products Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Guizhou Taibang Biological Products Recent Developments
11.8 Shanghai RAAS Blood Products
11.8.1 Shanghai RAAS Blood Products Corporation Information
11.8.2 Shanghai RAAS Blood Products Overview
11.8.3 Shanghai RAAS Blood Products Intravenous Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Shanghai RAAS Blood Products Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Shanghai RAAS Blood Products Recent Developments
11.9 Hualan Biological Engineering
11.9.1 Hualan Biological Engineering Corporation Information
11.9.2 Hualan Biological Engineering Overview
11.9.3 Hualan Biological Engineering Intravenous Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Hualan Biological Engineering Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hualan Biological Engineering Recent Developments
11.10 Kedrion S.p.A.
11.10.1 Kedrion S.p.A. Corporation Information
11.10.2 Kedrion S.p.A. Overview
11.10.3 Kedrion S.p.A. Intravenous Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Kedrion S.p.A. Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Kedrion S.p.A. Recent Developments
11.11 Beijing Tiantan Biological Products
11.11.1 Beijing Tiantan Biological Products Corporation Information
11.11.2 Beijing Tiantan Biological Products Overview
11.11.3 Beijing Tiantan Biological Products Intravenous Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 Beijing Tiantan Biological Products Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Beijing Tiantan Biological Products Recent Developments
11.12 China Biologic Products
11.12.1 China Biologic Products Corporation Information
11.12.2 China Biologic Products Overview
11.12.3 China Biologic Products Intravenous Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 China Biologic Products Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 China Biologic Products Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Intravenous Antibodies Value Chain Analysis
12.2 Intravenous Antibodies Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intravenous Antibodies Production Mode & Process
12.4 Intravenous Antibodies Sales and Marketing
12.4.1 Intravenous Antibodies Sales Channels
12.4.2 Intravenous Antibodies Distributors
12.5 Intravenous Antibodies Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Intravenous Antibodies Industry Trends
13.2 Intravenous Antibodies Market Drivers
13.3 Intravenous Antibodies Market Challenges
13.4 Intravenous Antibodies Market Restraints
14 Key Findings in The Global Intravenous Antibodies Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Intravenous Antibodies Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of IgG
Table 3. Major Manufacturers of IgA
Table 4. Major Manufacturers of IgM
Table 5. Major Manufacturers of IgE
Table 6. Major Manufacturers of IgD
Table 7. Global Intravenous Antibodies Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Intravenous Antibodies Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 9. Global Intravenous Antibodies Sales by Region (2016-2021) & (K Units)
Table 10. Global Intravenous Antibodies Sales Market Share by Region (2016-2021)
Table 11. Global Intravenous Antibodies Sales by Region (2022-2027) & (K Units)
Table 12. Global Intravenous Antibodies Sales Market Share by Region (2022-2027)
Table 13. Global Intravenous Antibodies Revenue by Region (2016-2021) & (US$ Million)
Table 14. Global Intravenous Antibodies Revenue Market Share by Region (2016-2021)
Table 15. Global Intravenous Antibodies Revenue by Region (2022-2027) & (US$ Million)
Table 16. Global Intravenous Antibodies Revenue Market Share by Region (2022-2027)
Table 17. Global Intravenous Antibodies Sales by Manufacturers (2016-2021) & (K Units)
Table 18. Global Intravenous Antibodies Sales Share by Manufacturers (2016-2021)
Table 19. Global Intravenous Antibodies Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 20. Global Intravenous Antibodies Revenue Share by Manufacturers (2016-2021)
Table 21. Intravenous Antibodies Price by Manufacturers 2016-2021 (US$/Unit)
Table 22. Global Intravenous Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Intravenous Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Antibodies as of 2020)
Table 24. Intravenous Antibodies Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Intravenous Antibodies Product Offered
Table 26. Date of Manufacturers Enter into Intravenous Antibodies Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Intravenous Antibodies Sales by Type (2016-2021) & (K Units)
Table 29. Global Intravenous Antibodies Sales by Type (2022-2027) & (K Units)
Table 30. Global Intravenous Antibodies Sales Share by Type (2016-2021)
Table 31. Global Intravenous Antibodies Sales Share by Type (2022-2027)
Table 32. Global Intravenous Antibodies Revenue by Type (2016-2021) & (US$ Million)
Table 33. Global Intravenous Antibodies Revenue by Type (2022-2027) & (US$ Million)
Table 34. Global Intravenous Antibodies Revenue Share by Type (2016-2021)
Table 35. Global Intravenous Antibodies Revenue Share by Type (2022-2027)
Table 36. Intravenous Antibodies Price by Type (2016-2021) & (US$/Unit)
Table 37. Global Intravenous Antibodies Price Forecast by Type (2022-2027) & (US$/Unit)
Table 38. Global Intravenous Antibodies Sales by Application (2016-2021) & (K Units)
Table 39. Global Intravenous Antibodies Sales by Application (2022-2027) & (K Units)
Table 40. Global Intravenous Antibodies Sales Share by Application (2016-2021)
Table 41. Global Intravenous Antibodies Sales Share by Application (2022-2027)
Table 42. Global Intravenous Antibodies Revenue by Application (2016-2021) & (US$ Million)
Table 43. Global Intravenous Antibodies Revenue by Application (2022-2027) & (US$ Million)
Table 44. Global Intravenous Antibodies Revenue Share by Application (2016-2021)
Table 45. Global Intravenous Antibodies Revenue Share by Application (2022-2027)
Table 46. Intravenous Antibodies Price by Application (2016-2021) & (US$/Unit)
Table 47. Global Intravenous Antibodies Price Forecast by Application (2022-2027) & (US$/Unit)
Table 48. North America Intravenous Antibodies Sales by Type (2016-2021) & (K Units)
Table 49. North America Intravenous Antibodies Sales by Type (2022-2027) & (K Units)
Table 50. North America Intravenous Antibodies Revenue by Type (2016-2021) & (US$ Million)
Table 51. North America Intravenous Antibodies Revenue by Type (2022-2027) & (US$ Million)
Table 52. North America Intravenous Antibodies Sales by Application (2016-2021) & (K Units)
Table 53. North America Intravenous Antibodies Sales by Application (2022-2027) & (K Units)
Table 54. North America Intravenous Antibodies Revenue by Application (2016-2021) & (US$ Million)
Table 55. North America Intravenous Antibodies Revenue by Application (2022-2027) & (US$ Million)
Table 56. North America Intravenous Antibodies Sales by Country (2016-2021) & (K Units)
Table 57. North America Intravenous Antibodies Sales by Country (2022-2027) & (K Units)
Table 58. North America Intravenous Antibodies Revenue by Country (2016-2021) & (US$ Million)
Table 59. North America Intravenous Antibodies Revenue by Country (2022-2027) & (US$ Million)
Table 60. Europe Intravenous Antibodies Sales by Type (2016-2021) & (K Units)
Table 61. Europe Intravenous Antibodies Sales by Type (2022-2027) & (K Units)
Table 62. Europe Intravenous Antibodies Revenue by Type (2016-2021) & (US$ Million)
Table 63. Europe Intravenous Antibodies Revenue by Type (2022-2027) & (US$ Million)
Table 64. Europe Intravenous Antibodies Sales by Application (2016-2021) & (K Units)
Table 65. Europe Intravenous Antibodies Sales by Application (2022-2027) & (K Units)
Table 66. Europe Intravenous Antibodies Revenue by Application (2016-2021) & (US$ Million)
Table 67. Europe Intravenous Antibodies Revenue by Application (2022-2027) & (US$ Million)
Table 68. Europe Intravenous Antibodies Sales by Country (2016-2021) & (K Units)
Table 69. Europe Intravenous Antibodies Sales by Country (2022-2027) & (K Units)
Table 70. Europe Intravenous Antibodies Revenue by Country (2016-2021) & (US$ Million)
Table 71. Europe Intravenous Antibodies Revenue by Country (2022-2027) & (US$ Million)
Table 72. Asia Pacific Intravenous Antibodies Sales by Type (2016-2021) & (K Units)
Table 73. Asia Pacific Intravenous Antibodies Sales by Type (2022-2027) & (K Units)
Table 74. Asia Pacific Intravenous Antibodies Revenue by Type (2016-2021) & (US$ Million)
Table 75. Asia Pacific Intravenous Antibodies Revenue by Type (2022-2027) & (US$ Million)
Table 76. Asia Pacific Intravenous Antibodies Sales by Application (2016-2021) & (K Units)
Table 77. Asia Pacific Intravenous Antibodies Sales by Application (2022-2027) & (K Units)
Table 78. Asia Pacific Intravenous Antibodies Revenue by Application (2016-2021) & (US$ Million)
Table 79. Asia Pacific Intravenous Antibodies Revenue by Application (2022-2027) & (US$ Million)
Table 80. Asia Pacific Intravenous Antibodies Sales by Region (2016-2021) & (K Units)
Table 81. Asia Pacific Intravenous Antibodies Sales by Region (2022-2027) & (K Units)
Table 82. Asia Pacific Intravenous Antibodies Revenue by Region (2016-2021) & (US$ Million)
Table 83. Asia Pacific Intravenous Antibodies Revenue by Region (2022-2027) & (US$ Million)
Table 84. Latin America Intravenous Antibodies Sales by Type (2016-2021) & (K Units)
Table 85. Latin America Intravenous Antibodies Sales by Type (2022-2027) & (K Units)
Table 86. Latin America Intravenous Antibodies Revenue by Type (2016-2021) & (US$ Million)
Table 87. Latin America Intravenous Antibodies Revenue by Type (2022-2027) & (US$ Million)
Table 88. Latin America Intravenous Antibodies Sales by Application (2016-2021) & (K Units)
Table 89. Latin America Intravenous Antibodies Sales by Application (2022-2027) & (K Units)
Table 90. Latin America Intravenous Antibodies Revenue by Application (2016-2021) & (US$ Million)
Table 91. Latin America Intravenous Antibodies Revenue by Application (2022-2027) & (US$ Million)
Table 92. Latin America Intravenous Antibodies Sales by Country (2016-2021) & (K Units)
Table 93. Latin America Intravenous Antibodies Sales by Country (2022-2027) & (K Units)
Table 94. Latin America Intravenous Antibodies Revenue by Country (2016-2021) & (US$ Million)
Table 95. Latin America Intravenous Antibodies Revenue by Country (2022-2027) & (US$ Million)
Table 96. Middle East and Africa Intravenous Antibodies Sales by Type (2016-2021) & (K Units)
Table 97. Middle East and Africa Intravenous Antibodies Sales by Type (2022-2027) & (K Units)
Table 98. Middle East and Africa Intravenous Antibodies Revenue by Type (2016-2021) & (US$ Million)
Table 99. Middle East and Africa Intravenous Antibodies Revenue by Type (2022-2027) & (US$ Million)
Table 100. Middle East and Africa Intravenous Antibodies Sales by Application (2016-2021) & (K Units)
Table 101. Middle East and Africa Intravenous Antibodies Sales by Application (2022-2027) & (K Units)
Table 102. Middle East and Africa Intravenous Antibodies Revenue by Application (2016-2021) & (US$ Million)
Table 103. Middle East and Africa Intravenous Antibodies Revenue by Application (2022-2027) & (US$ Million)
Table 104. Middle East and Africa Intravenous Antibodies Sales by Country (2016-2021) & (K Units)
Table 105. Middle East and Africa Intravenous Antibodies Sales by Country (2022-2027) & (K Units)
Table 106. Middle East and Africa Intravenous Antibodies Revenue by Country (2016-2021) & (US$ Million)
Table 107. Middle East and Africa Intravenous Antibodies Revenue by Country (2022-2027) & (US$ Million)
Table 108. Baxter International Corporation Information
Table 109. Baxter International Description and Major Businesses
Table 110. Baxter International Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Baxter International Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Baxter International Recent Developments
Table 113. CSL Limited Corporation Information
Table 114. CSL Limited Description and Major Businesses
Table 115. CSL Limited Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. CSL Limited Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. CSL Limited Recent Developments
Table 118. Biotest AG Corporation Information
Table 119. Biotest AG Description and Major Businesses
Table 120. Biotest AG Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Biotest AG Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Biotest AG Recent Developments
Table 123. OMRIX Biopharmaceuticals Corporation Information
Table 124. OMRIX Biopharmaceuticals Description and Major Businesses
Table 125. OMRIX Biopharmaceuticals Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. OMRIX Biopharmaceuticals Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. OMRIX Biopharmaceuticals Recent Developments
Table 128. Octapharma AG Corporation Information
Table 129. Octapharma AG Description and Major Businesses
Table 130. Octapharma AG Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Octapharma AG Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Octapharma AG Recent Developments
Table 133. Grifols, S.A Corporation Information
Table 134. Grifols, S.A Description and Major Businesses
Table 135. Grifols, S.A Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Grifols, S.A Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Grifols, S.A Recent Developments
Table 138. Guizhou Taibang Biological Products Corporation Information
Table 139. Guizhou Taibang Biological Products Description and Major Businesses
Table 140. Guizhou Taibang Biological Products Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Guizhou Taibang Biological Products Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Guizhou Taibang Biological Products Recent Developments
Table 143. Shanghai RAAS Blood Products Corporation Information
Table 144. Shanghai RAAS Blood Products Description and Major Businesses
Table 145. Shanghai RAAS Blood Products Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 146. Shanghai RAAS Blood Products Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Shanghai RAAS Blood Products Recent Developments
Table 148. Hualan Biological Engineering Corporation Information
Table 149. Hualan Biological Engineering Description and Major Businesses
Table 150. Hualan Biological Engineering Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 151. Hualan Biological Engineering Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Hualan Biological Engineering Recent Developments
Table 153. Kedrion S.p.A. Corporation Information
Table 154. Kedrion S.p.A. Description and Major Businesses
Table 155. Kedrion S.p.A. Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 156. Kedrion S.p.A. Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Kedrion S.p.A. Recent Developments
Table 158. Beijing Tiantan Biological Products Corporation Information
Table 159. Beijing Tiantan Biological Products Description and Major Businesses
Table 160. Beijing Tiantan Biological Products Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 161. Beijing Tiantan Biological Products Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Beijing Tiantan Biological Products Recent Developments
Table 163. China Biologic Products Corporation Information
Table 164. China Biologic Products Description and Major Businesses
Table 165. China Biologic Products Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 166. China Biologic Products Intravenous Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. China Biologic Products Recent Developments
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Intravenous Antibodies Distributors List
Table 171. Intravenous Antibodies Customers List
Table 172. Intravenous Antibodies Market Trends
Table 173. Intravenous Antibodies Market Drivers
Table 174. Intravenous Antibodies Market Challenges
Table 175. Intravenous Antibodies Market Restraints
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Antibodies Product Picture
Figure 2. Global Intravenous Antibodies Market Share by Type in 2020 & 2027
Figure 3. IgG Product Picture
Figure 4. IgA Product Picture
Figure 5. IgM Product Picture
Figure 6. IgE Product Picture
Figure 7. IgD Product Picture
Figure 8. Global Intravenous Antibodies Market Share by Application in 2020 & 2027
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Others
Figure 12. Intravenous Antibodies Report Years Considered
Figure 13. Global Intravenous Antibodies Sales 2016-2027 (K Units)
Figure 14. Global Intravenous Antibodies Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Intravenous Antibodies Revenue 2016-2027 (US$ Million)
Figure 16. Global Intravenous Antibodies Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 17. Global Intravenous Antibodies Sales Market Share by Region (2016-2021)
Figure 18. Global Intravenous Antibodies Sales Market Share by Region (2022-2027)
Figure 19. North America Intravenous Antibodies Sales YoY (2016-2027) & (K Units)
Figure 20. North America Intravenous Antibodies Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Europe Intravenous Antibodies Sales YoY (2016-2027) & (K Units)
Figure 22. Europe Intravenous Antibodies Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Asia-Pacific Intravenous Antibodies Sales YoY (2016-2027) & (K Units)
Figure 24. Asia-Pacific Intravenous Antibodies Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Latin America Intravenous Antibodies Sales YoY (2016-2027) & (K Units)
Figure 26. Latin America Intravenous Antibodies Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Middle East & Africa Intravenous Antibodies Sales YoY (2016-2027) & (K Units)
Figure 28. Middle East & Africa Intravenous Antibodies Revenue YoY (2016-2027) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Intravenous Antibodies Sales in 2020
Figure 30. The Top 10 and Top 5 Players Market Share by Intravenous Antibodies Revenue in 2020
Figure 31. Intravenous Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 32. Global Intravenous Antibodies Sales Market Share by Type (2016-2027)
Figure 33. Global Intravenous Antibodies Revenue Market Share by Type (2016-2027)
Figure 34. Global Intravenous Antibodies Sales Market Share by Application (2016-2027)
Figure 35. Global Intravenous Antibodies Revenue Market Share by Application (2016-2027)
Figure 36. North America Intravenous Antibodies Sales Market Share by Type (2016-2027)
Figure 37. North America Intravenous Antibodies Revenue Market Share by Type (2016-2027)
Figure 38. North America Intravenous Antibodies Sales Market Share by Application (2016-2027)
Figure 39. North America Intravenous Antibodies Revenue Market Share by Application (2016-2027)
Figure 40. North America Intravenous Antibodies Sales Share by Country (2016-2027)
Figure 41. North America Intravenous Antibodies Revenue Share by Country (2016-2027)
Figure 42. United States Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 43. Canada Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 44. Europe Intravenous Antibodies Sales Market Share by Type (2016-2027)
Figure 45. Europe Intravenous Antibodies Revenue Market Share by Type (2016-2027)
Figure 46. Europe Intravenous Antibodies Sales Market Share by Application (2016-2027)
Figure 47. Europe Intravenous Antibodies Revenue Market Share by Application (2016-2027)
Figure 48. Europe Intravenous Antibodies Sales Share by Country (2016-2027)
Figure 49. Europe Intravenous Antibodies Revenue Share by Country (2016-2027)
Figure 50. Germany Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 51. France Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 52. U.K. Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 53. Italy Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 54. Russia Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 55. Asia Pacific Intravenous Antibodies Sales Market Share by Type (2016-2027)
Figure 56. Asia Pacific Intravenous Antibodies Revenue Market Share by Type (2016-2027)
Figure 57. Asia Pacific Intravenous Antibodies Sales Market Share by Application (2016-2027)
Figure 58. Asia Pacific Intravenous Antibodies Revenue Market Share by Application (2016-2027)
Figure 59. Asia Pacific Intravenous Antibodies Sales Share by Region (2016-2027)
Figure 60. Asia Pacific Intravenous Antibodies Revenue Share by Region (2016-2027)
Figure 61. China Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 62. Japan Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 63. South Korea Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 64. India Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 65. Australia Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 66. China Taiwan Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 67. Indonesia Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 68. Thailand Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 69. Malaysia Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 70. Latin America Intravenous Antibodies Sales Market Share by Type (2016-2027)
Figure 71. Latin America Intravenous Antibodies Revenue Market Share by Type (2016-2027)
Figure 72. Latin America Intravenous Antibodies Sales Market Share by Application (2016-2027)
Figure 73. Latin America Intravenous Antibodies Revenue Market Share by Application (2016-2027)
Figure 74. Latin America Intravenous Antibodies Sales Share by Country (2016-2027)
Figure 75. Latin America Intravenous Antibodies Revenue Share by Country (2016-2027)
Figure 76. Mexico Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 77. Brazil Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 78. Argentina Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 79. Middle East and Africa Intravenous Antibodies Sales Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Intravenous Antibodies Revenue Market Share by Type (2016-2027)
Figure 81. Middle East and Africa Intravenous Antibodies Sales Market Share by Application (2016-2027)
Figure 82. Middle East and Africa Intravenous Antibodies Revenue Market Share by Application (2016-2027)
Figure 83. Middle East and Africa Intravenous Antibodies Sales Share by Country (2016-2027)
Figure 84. Middle East and Africa Intravenous Antibodies Revenue Share by Country (2016-2027)
Figure 85. Turkey Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 86. Saudi Arabia Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 87. UAE Intravenous Antibodies Revenue (2016-2027) & (US$ Million)
Figure 88. Intravenous Antibodies Value Chain
Figure 89. Intravenous Antibodies Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
静脈内栄養補給のグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Intravenous Feeding Market The global Intravenous Feeding market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Intravenous Feeding Scope and Segment Intravenous…- 中心子周辺物質1（PCM1）のグローバル市場インサイト・予測（～2027年） Pericentriolar material 1, also known as PCM1, is a protein which in humans is encoded by the PCM1 gene.The PCM1 protein was originally identified by virtue of its distinct cell cycle-dependent association with the centrosome complex and microtubules. Market Analysis and Insights: Global Pericentrio…
- 神経パッチのグローバル市場インサイト・予測（～2027年） Nerve Patch is a kind of synthetic dura replacement material. It is made of high purity polyester urane material with special process to form a porous woolen structure. Its excellent fibrous tissue structure can support the rapid infiltration and proliferation of fibroblasts.The product has high ten…
- 小児用動脈フィルターのグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Pediatric Arterial Filters Market The global Pediatric Arterial Filters market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027. Global Pediatric Arterial Filters Scope and Segmen…
- 小児用静脈ファインダーのグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Pediatric Vein Finder Market The global Pediatric Vein Finder market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Pediatric Vein Finder Scope and Segment Pedia…